Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 7, 1999, Pages 2349-2352

  Pivonello, Rosario ^a   Faggiano, Antongiulio ^a   Di Somma, Carolina ^a   Klain, Michele ^a   Filippella, Mariagiovanna ^a   Salvatore, Marco ^a   Lombardi, Gaetano ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; ALENDRONIC ACID; COLLAGEN TYPE 1; CREATININE; FOLLITROPIN; LUTEINIZING HORMONE; OSTEOCALCIN;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES INSIPIDUS; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LUMBAR SPINE; MALE; OSTEOPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033306105     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.7.5816     Document Type: Article

References (29)

1. Diabetes insipidus
2. Impairment of bone status in patients with central diabetes insipidus
3. Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus
4. Effect of oral alendronate on bone mineral density and the incidence of fractures in post-menopausal osteoporosis
5. Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease
6. Age and bone mass as predictors of fractures in a prospective study
7. Polyuric states in man
8. Vasopressin and its neurophysins
9. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria
10. New approach to diagnosis of growth hormone deficiency in adults
11. Antidiuretic hormone increases renal prostaglandin synthesis in vivo
12. Mechanism of action of vasopressin hormones on prostaglandin synthesis in the kidney
13. 2α) on bone
14. Regulation of bone formation
15. 2 production
16. The role of prostaglandins in the regulation of bone metabolism
17. The in vivo anabolic actions of prostaglandins on bone
18. Altered PG production by glomeruli and papilla of rats with hereditary diabetes insipidus
19. Renal prostaglandins and water balance: Studies in normal volunteer subjects and in patients with central diabetes insipidus
20. Enhanced adrenocorticotrophic hormone and cortisol response to corticotrophin-releasing hormone in central idiopathic diabetes insipidus
21. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus
22. Mechanism of glucocorticoid action on bone: Implications to glucocorticoid-induced osteoporosis
23. Glucocorticoid induced osteoporosis
24. Glucocorticoid-induced osteoporosis: Pathogenesis and management
25. Corticosteroid osteoporosis
26. Randomised trial of effect of alendronate on risk of fractures in women with existing vertebral fractures
27. Dose response relationship for alendronate treatment in osteoporotic elderly women
28. Pre-existing fractures and bone mass predict vertebral fracture incidence in women
29. Predicting various fragility fractures in women by forearm bone densitometry: A follow-up study